The Cochrane Library: Cochrane Database of Systematic Reviews

DOI: 10.1002/14651858

Reviews/Protocols listed by Cochrane Review Group

  1. Cochrane Acute Respiratory Infections Group
  2. Cochrane Airways Group
  3. Cochrane Anaesthesia Group
  4. Cochrane Back Group
  5. Cochrane Bone, Joint and Muscle Trauma Group
  6. Cochrane Breast Cancer Group
  7. Cochrane Childhood Cancer Group
  8. Cochrane Colorectal Cancer Group
  9. Cochrane Consumers and Communication Group
  10. Cochrane Cystic Fibrosis and Genetic Disorders Group
  11. Cochrane Dementia and Cognitive Improvement Group
  12. Cochrane Depression, Anxiety and Neurosis Group
  13. Cochrane Developmental, Psychosocial and Learning Problems Group
  14. Cochrane Drugs and Alcohol Group
  15. Cochrane Ear, Nose and Throat Disorders Group
  16. Cochrane Effective Practice and Organisation of Care Group
  17. Cochrane Epilepsy Group
  18. Cochrane Eyes and Vision Group
  19. Cochrane Fertility Regulation Group
  20. Cochrane Gynaecological Cancer Group
  21. Cochrane Haematological Malignancies Group
  22. Cochrane Heart Group
  23. Cochrane Hepato-Biliary Group
  24. Cochrane HIV/AIDS Group
  25. Cochrane Hypertension Group
  26. Cochrane Incontinence Group
  27. Cochrane Infectious Diseases Group
  28. Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Group
  29. Cochrane Injuries Group
  30. Cochrane Lung Cancer Group
  31. Cochrane Menstrual Disorders and Subfertility Group
  32. Cochrane Metabolic and Endocrine Disorders Group
  33. Cochrane Methodology Review Group
  34. Cochrane Movement Disorders Group
  35. Cochrane Multiple Sclerosis and Rare Diseases of the Central Nervous System Group
  36. Cochrane Musculoskeletal Group
  37. Cochrane Neonatal Group
  38. Cochrane Neuromuscular Disease Group
  39. Cochrane Occupational Safety and Health Group
  40. Cochrane Oral Health Group
  41. Cochrane Pain, Palliative and Supportive Care Group
  42. Cochrane Peripheral Vascular Diseases Group
  43. Cochrane Pregnancy and Childbirth Group
  44. Cochrane Prostatic Diseases and Urologic Cancers Group
  45. Cochrane Public Health Group
  46. Cochrane Renal Group
  47. Cochrane Schizophrenia Group
  48. Cochrane Sexually Transmitted Infections Group
  49. Cochrane Skin Group
  50. Cochrane Stroke Group
  51. Cochrane Tobacco Addiction Group
  52. Cochrane Upper Gastrointestinal and Pancreatic Diseases Group
    1. About this group
    2. Reviews
      1. Abdominal drainage versus no drainage post gastrectomy for gastric cancerReview
      2. Additional bedtime H2-receptor antagonist for the control of nocturnal gastric acid breakthroughReview
      3. Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitisReview
      4. Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescentsReview
      5. Argon plasma coagulation therapy for acute non-variceal upper gastrointestinal bleedingReview
      6. Chemotherapy and radiotherapy for inoperable advanced pancreatic cancerReview
      7. Chemotherapy for advanced gastric cancerReview
      8. Chemotherapy for metastatic carcinoma of the esophagus and gastro-esophageal junctionReview
      9. Chinese herbal medicines for acute pancreatitisReview
      10. Chinese herbal medicines for esophageal cancerReview
      11. Chinese herbal medicines for induction of remission in advanced or late gastric cancerReview
      12. Cisapride treatment for gastro-oesophageal reflux in childrenReview
      13. Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagusReviewWithdrawn
      14. Comparison of different regimens of proton pump inhibitors for acute peptic ulcer bleedingReview
      15. Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancerReviewDiagnostic
      16. Early routine endoscopic retrograde cholangiopancreatography strategy versus early conservative management strategy in acute gallstone pancreatitisReview
      17. Early versus delayed laparoscopic cholecystectomy for acute gallstone pancreatitisReview
      18. Endoscopic mucosal resection for early gastric cancerReview
      19. Endoscopic or surgical intervention for painful obstructive chronic pancreatitisReview
      20. Endoscopic pneumatic dilation versus botulinum toxin injection in the management of primary achalasiaReview
      21. Endoscopic retrograde cholangiopancreatography in gallstone-associated acute pancreatitisReviewWithdrawn
      22. Enteral versus parenteral nutrition for acute pancreatitisReview
      23. Epinephrine injection versus epinephrine injection and a second endoscopic method in high risk bleeding ulcersReview
      24. Eradication of Helicobacter pylori for non-ulcer dyspepsiaReviewWithdrawn
      25. Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patientsReview
      26. Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomachReview
      27. Guidewire-assisted cannulation of the common bile duct for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitisReview
      28. Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcerReview
      29. Initial management strategies for dyspepsiaReview
      30. Interventions for dysphagia in oesophageal cancerReviewWithdrawn
      31. Laparoscopic repair for perforated peptic ulcer diseaseReview
      32. Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux diseaseReviewWithdrawn
      33. Medical treatments in the short term management of reflux oesophagitisReviewWithdrawn
      34. Medical versus surgical management for gastro-oesophageal reflux disease (GORD) in adultsReview
      35. Metoclopramide for migration of naso-enteral tubeReview
      36. Metoclopramide, thickened feedings, and positioning for gastro-oesophageal reflux in children under two yearsReview
      37. Neoadjuvant chemotherapy versus none for resectable gastric cancerReviewWithdrawn
      38. Nitrates for achalasiaReview
      39. Non-surgical interventions for eosinophilic esophagitisReview
      40. Omentoplasty for esophagogastrostomy after esophagectomyReview
      41. Opioids for acute pancreatitis painReview
      42. Optimum duration of regimens for Helicobacter pylori eradicationReview
      43. Palliative biliary stents for obstructing pancreatic carcinomaReview
      44. Pancreatic enzymes for chronic pancreatitisReview
      45. Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbancesReview
      46. Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagusReview
      47. Pharmacological interventions for non-ulcer dyspepsiaReviewWithdrawn
      48. Post-surgical chemotherapy versus surgery alone for resectable gastric cancerReview
      49. Preoperative chemotherapy for resectable thoracic esophageal cancerReview
      50. Preoperative radiotherapy for esophageal carcinomaReview
      51. Prevention of NSAID-induced gastroduodenal ulcersReview
      52. Prophylactic gastrojejunostomy for unresectable periampullary carcinomaReview
      53. Proton pump inhibitor treatment for acute peptic ulcer bleedingReview
      54. Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleedingReview
      55. Psychological interventions for non-ulcer dyspepsiaReviewWithdrawn
      56. Pylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinomaReview
      57. Red cell transfusion for the management of upper gastrointestinal haemorrhageReview
      58. Resection versus other treatments for locally advanced pancreatic cancerReview
      59. Screening for oesophageal cancerReview
      60. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux diseaseReview
      61. Somatostatin analogues for pancreatic surgeryReview
      62. Stents for the prevention of pancreatic fistula following pancreaticoduodenectomyReview
      63. Surgery versus radical endotherapies for early cancer and high-grade dysplasia in Barrett's oesophagusReview
      64. Surveillance of gastric intestinal metaplasia for the prevention of gastric cancerReview
      65. Tranexamic acid for upper gastrointestinal bleedingReview
      66. Treatment for Barrett's oesophagusReview
    3. Protocols
      1. Acupuncture for functional dyspepsiaProtocol
      2. Antacids and lifestyle advice for reflux oesophagitis and Endoscopy Negative Reflux DiseaseProtocol
      3. Antidepressants and anxiolytics for functional dyspepsiaProtocol
      4. Antioxidants for acute pancreatitisProtocol
      5. Antioxidants for pain in chronic pancreatitisProtocol
      6. Antiproteases for acute pancreatitisProtocol
      7. Biodegradable anastomotic ring for gastrointestinal anastomosisProtocol
      8. Botulinum toxin for upper oesophageal sphincter dysfunction in neurological swallowing disordersProtocol
      9. Carbon dioxide detection for testing nasogastric tube placement in adultsProtocolDiagnostic
      10. Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancerProtocol
      11. Chinese herbal medicine alone or combined with vitamins for gastric precancerous lesionsProtocol
      12. Chinese herbal medicine for advanced pancreatic cancerProtocol
      13. Conservative interventions for the management of impacted food bolus in the oesophagusProtocol
      14. Diagnostic accuracy of endoscopic ultrasonography (EUS) for the preoperative locoregional staging of primary gastric cancerProtocolDiagnostic
      15. Electrosurgical current for endoscopic biliary sphincterotomy (EBS) for the prevention of post endoscopic retrograde cholangiopancreatography (ERCP) pancreatitisProtocol
      16. Endoscopic drainage with or without endo-ultrasonography for pancreatic pseudocystProtocol
      17. Endoscopic intervention for the prevention of post endoscopic retrograde cholangiopancreatography (ERCP) pancreatitisProtocolWithdrawn
      18. Enteral nutrition formulations for acute pancreatitisProtocol
      19. Fasting for haemostasis in children with gastrointestinal bleedingProtocol
      20. Fibrin sealants for the prevention of postoperative pancreatic fistula following pancreatic surgeryProtocol
      21. Helicobacter pylori eradication for premalignant lesions of the gastric mucosaProtocol
      22. Helicobacter pylori eradication for the prevention of gastric neoplasiaProtocol
      23. High dose versus standard dose proton pump inhibitor for short term management of erosive reflux oesophagitisProtocol
      24. Imaging modalities for characterising focal pancreatic lesionsProtocolDiagnostic
      25. Imatinib mesylate for gastrointestinal stromal tumours (GISTs)ProtocolWithdrawn
      26. Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care unitsProtocol
      27. Intraperitoneal chemotherapy for gastric carcinomaProtocol
      28. Laparoscopic cardiomyotomy versus endoscopic pneumatic dilation for primary achalasiaProtocol
      29. Laparoscopic fundoplication for gastro-oesophageal reflux disease (GORD) in adultsProtocol
      30. Lexipafant for acute pancreatitisProtocol
      31. Long term proton pump inhibitor (PPI) use and incidence of gastric premalignant lesionsProtocol
      32. Mesh reinforcement versus primary repair in laparoscopic paraoesophageal hernia repairs of the hiatusProtocol
      33. Nasogastric versus nasojejunal tube feeding for severe acute pancreatitisProtocol
      34. Nonsteroidal anti-inflammatories (NSAIDs) and aspirin for intestinal metaplasia of the stomachProtocol
      35. Pancreatic duct guidewire placement for biliary cannulation for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP)Protocol
      36. Percutaneous endoscopic gastrostomy versus radiologically placed gastrostomies for swallowing disturbancesProtocol
      37. Periodontal therapy as adjunctive treatment for gastric Helicobacter pylori infectionProtocol
      38. Pharmacologic and radiotherapeutic interventions for advanced pancreatic cancerProtocol
      39. Pharmacological treatment for gastro-oesophageal reflux in childrenProtocol
      40. Postoperative chemotherapy or radiotherapy for esophageal cancerProtocol
      41. Preoperative radiotherapy chemotherapy and surgery versus surgery alone for esophageal cancerProtocol
      42. Probiotics as adjunctive therapy for eradication of Helicobacter pylori infectionProtocol
      43. Prokinetics for functional dyspepsiaProtocol
      44. Prophylactic abdominal drainage for pancreatic surgeryProtocol
      45. Proton pump inhibitor-based triple therapies versus dual therapies for Helicobacter pylori eradicationProtocol
      46. Proton pump inhibitor versus placebo in the short term management of gastro-esophageal reflux diseaseProtocol
      47. Routine cholecystectomy during Roux-en-Y gastric bypass with or without choledocholithiasisProtocol
      48. Sequential versus standard triple therapy for Helicobacter pylori eradicationProtocol
      49. Somatostatin analogues for carcinoid syndromeProtocol
      50. Somatostatin or somatostatin analogues for acute non-variceal upper gastrointestinal bleedingProtocol
      51. Stapler versus scalpel resection followed by hand-sewn closure of the pancreatic remnant for distal pancreatectomyProtocol
  53. Cochrane Wounds Group